We studied the immunogenic B78ChOVA subcutaneous tumor model that is a B16 variant expressing OVA and mCherry fluorescent protein (2) and that elicits cDC1-mediated antitumor CD8+ T cell responses (2, 3). This evidence concerns the gene CD8A and neoplasm.